Mariella sat in her car outside a slimming clinic in Malta, engine off, hands in her lap. She'd been sitting there for six minutes.
Last reviewed by the Carisma Medical Team — 2026
Mariella sat in her car outside a slimming clinic in Malta, engine off, hands in her lap. She'd been sitting there for six minutes. Inside her bag was a notebook she'd filled with questions — questions she'd been embarrassed to ask a GP who always seemed too rushed, questions she'd typed into Google at midnight, questions she wasn't sure anyone could actually answer.
She was 44. She'd tried every diet that had a name. She'd done the shakes, the points, the cutting carbs entirely for seven weeks until she was crying over a bowl of pasta at her sister's birthday dinner. Each time, something worked — for a while. Each time, the weight came back, plus a little extra for good measure. She felt like her body was working against her. The truth, which no one had ever properly explained to her, was that it was.
She walked through those clinic doors anyway.
That moment — cautious, exhausted, carrying two decades of trying — is exactly where medical weight loss Malta begins for many women. And it is not a failure to arrive there. It is, for a great many people, the first time they will get the right kind of help.
Key Takeaways - Medical weight loss Malta involves a qualified doctor overseeing your entire programme — not just a diet plan - GLP-1 receptor agonist medications (like semaglutide and tirzepatide) reduce appetite by working with your own biology - Clinical trials show 15–21% body weight reduction; results may vary for each individual - You do not need a GP referral to book your first consultation at Carisma Slimming - A supervised programme offers dose adjustments, blood work monitoring, and a safety net self-directed dieting cannot provide
What Makes Weight Loss 'Medical'?
Medical weight loss is a structured, clinically supervised approach to managing body weight — one that involves qualified healthcare professionals, evidence-based treatments, and ongoing medical oversight. It is not a diet plan you follow at home. It is not a supplement regime sold online. It is not personal training with a nutrition guide attached.
The "medical" in medical weight loss means a doctor is involved — in your assessment, in selecting the right treatment for your specific body and health history, and in monitoring your progress over time.
The difference between a clinic and a gym programme
A gym programme asks how much you want to lose and gives you a workout plan. A medical weight loss clinic asks why you've been struggling — because the answer is almost never "not trying hard enough."
At a medically supervised clinic, the starting point is your biology, not your willpower. Your hormones, your metabolic rate, your blood markers, your medication history, your sleep patterns — all of it is relevant information. A doctor can review what has been happening in your body and design a programme that works with your physiology rather than against it.
Why doctor oversight changes outcomes
When a qualified clinician is guiding your programme, decisions are made on evidence, not guesswork. Doses can be adjusted. Blood work can flag issues before they become problems. If you plateau, there is a clinical reason — and a clinical response. You are not left to wonder why the number on the scale stopped moving and told to just try harder.
Medically supervised weight loss programmes produce meaningfully different outcomes from self-directed approaches — not because the patients are more disciplined, but because the intervention is more precise.
Who Is Medical Weight Loss For?
The short answer: more people than most assume. Medical weight loss in Malta is not reserved for those with extreme obesity or complex medical histories. It is appropriate for any adult who has a genuine health motivation to manage their weight and who has found that standard approaches have not delivered lasting results.
When diet and exercise alone haven't worked
If you have made genuine, sustained efforts to change your diet and increase your activity — and you still are not seeing the results you need — that is clinically significant information. It suggests that behaviour change alone may not be sufficient for your body, and that a medical framework may be what is actually missing.
This is not a reflection of your character. Research has established that weight regulation is driven by hormones, genetics, gut microbiome, sleep quality, stress, and metabolic rate — none of which respond to effort alone.
Health conditions that make medical support important
Medical weight loss becomes particularly important when weight is connected to, or contributing to, other health conditions. This includes type 2 diabetes or pre-diabetes, hypertension, high cholesterol, obstructive sleep apnoea, polycystic ovary syndrome (PCOS), and joint conditions worsened by excess weight. In these cases, weight management is genuinely clinical — and the support of a doctor is not optional; it is necessary.
Many women who come to a weight loss clinic in Malta are carrying one or more of these conditions. Managing weight medically can reduce medication requirements, improve blood glucose control, and lower cardiovascular risk — outcomes that go well beyond the number on the scale.
What Happens at a Medical Weight Loss Clinic in Malta?
Walking into a medically supervised slimming clinic for the first time can feel uncertain. Knowing what to expect takes the anxiety out of that first step.
Your first consultation
Your initial consultation is not a weigh-in with a sales pitch attached. It is a clinical conversation. A doctor or qualified clinician will take your full medical history — what you have tried, what medications you take, what your daily life looks like, where your weight has been over time, and what your goals actually are. You are not judged for your history. You are understood because of it.
This consultation is also where you ask the questions you have been sitting on. No question about your health, your body, or your concerns is too small.
Assessment, blood work, and goal-setting
After your history is taken, your team will typically carry out a physical assessment, which may include BMI and body composition measurements, blood pressure, and in many cases blood work — checking thyroid function, glucose levels, cholesterol, and relevant hormonal markers. This is not a tick-box exercise. These results shape everything that follows.
Goal-setting in a medically supervised programme is realistic and personalised. Your targets are based on your starting point, your health status, and what a safe, sustainable rate of progress looks like for you specifically. Results may vary for each individual — and your programme is built around your specific profile, not a generic template.
You can learn more about what your first visit involves by visiting our free slimming consultation at Carisma page — where you can book a no-obligation, pressure-free appointment with our clinical team.
GLP-1 Injections: The Cornerstone of Medical Weight Loss in Malta
For many patients in medically supervised programmes, GLP-1 receptor agonist medications form the central part of their treatment plan. These are injectable medications that work with your body's own biology to reduce appetite, slow digestion, and support sustained weight loss.
How GLP-1 medications support your biology
GLP-1 (glucagon-like peptide-1) is a hormone your gut naturally produces after eating. It signals to your brain that you have eaten, slows the passage of food through your stomach, and helps regulate blood glucose. In people with obesity, this signal can be insufficient or overridden — meaning fullness cues arrive late, or not at all.
GLP-1 receptor agonists mimic this hormone. They act on receptors in the hypothalamus — the area of the brain that governs appetite — to reduce hunger and food intake. They slow gastric emptying, so you feel full for longer after smaller portions. And they support glucose-dependent insulin release from the pancreas, which improves blood sugar regulation and helps address underlying insulin resistance that many patients carry without knowing it.
The result is a meaningful, medically supported reduction in caloric intake — not through restriction and willpower, but through restoring the biological signals your body was struggling to produce on its own.
Ozempic, Mounjaro and what's available in Malta
Two medications in this class are most commonly used in medically supervised weight loss programmes: semaglutide (known under the brand name Ozempic at diabetes doses, and Wegovy at the weight management dose) and tirzepatide (Mounjaro).
Semaglutide at 2.4mg weekly is a GLP-1 receptor agonist. Clinical trial data from the STEP-1 trial (Wilding et al., NEJM 2021, n=1,961 adults) showed a mean body weight reduction of 14.9% over 68 weeks, compared to 2.4% in the placebo group. 86.4% of semaglutide participants achieved at least 5% body weight reduction. 69.1% achieved at least 10% reduction.
Tirzepatide (Mounjaro) is a newer dual-action medication — it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously. This dual mechanism appears to produce additive effects on appetite suppression and energy metabolism. In the SURMOUNT-1 trial (Jastreboff et al., NEJM 2022, n=2,539 adults without type 2 diabetes, 72 weeks), mean body weight reductions were 15.0% (5mg dose), 19.5% (10mg), and 20.9% (15mg), compared to 3.1% in the placebo group. At the 15mg dose, 56.7% of participants achieved at least 20% body weight reduction — a threshold previously unachievable with any approved anti-obesity medication.
Mounjaro received EMA approval for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related health condition in November 2023.
Availability of specific medications in Malta is determined by your prescribing doctor based on your health profile, medical history, and eligibility criteria. Our GLP-1 medical weight loss programme page explains how these medications are used within a supervised clinical framework at Carisma Slimming.
What Results Can You Realistically Expect?
Honest expectations are one of the most important things a medically supervised programme can give you. Here is what the clinical evidence shows — and what it does not guarantee.
Average weight loss timelines
In medically supervised programmes using GLP-1 receptor agonists, clinical trial data show typical results building gradually over weeks and months. The early weeks (weeks 1–4) are a titration period — the dose is being established, your body is adapting, and changes may be modest. The most active phase of loss typically occurs between weeks 4 and 16 as the therapeutic dose takes effect. Progress decelerates as you approach weeks 16–36, and most patients reach a stable, lower weight plateau by weeks 36–72.
Across the class of GLP-1 receptor agonist medications, clinical trials demonstrate 5–21% sustained body weight loss under trial conditions. Real-world outcomes vary based on individual factors including starting weight, adherence to dietary guidance, physical activity, metabolic health, and the specific medication and dose prescribed. Results may vary for each individual, and your clinical team will set targets appropriate to your personal profile.
If you are curious about the full range of clinically supervised slimming options available, our weight loss overview page covers every pathway we offer — including both medical and non-medical treatments.
Why sustainable loss matters more than speed
Beyond the scale, meaningful changes occur throughout a well-supported medical weight loss journey. These are the outcomes that matter most to the women who go through our programme:
Climbing two flights of stairs without stopping at the top. Carrying shopping from the car in a single trip without needing to rest. Sleeping through the night without waking breathless. Having the energy to play with your children on the floor — and get back up again without thinking about it. Fitting into a seatbelt without discomfort. Crossing your legs comfortably when you sit down. Wearing the shoes that only used to fit in the morning before your feet swelled. Reducing — or in some cases eliminating, under doctor supervision — a daily medication your doctor has been reviewing.
These are the wins that change daily life. And they often arrive before the number on the scale has moved as far as you hoped it would.
Safety: What Doctor Supervision Actually Provides
Medical supervision is not a marketing phrase. It describes a clinical reality that makes medically supervised slimming meaningfully safer than self-directed attempts — and meaningfully more effective when things do not go as expected.
Monitoring side effects and adjusting doses
GLP-1 receptor agonist medications have a well-documented side effect profile that is manageable when monitored by a doctor. The most common side effects are gastrointestinal — nausea, occasional vomiting, diarrhoea, or constipation. In the SURMOUNT-1 trial, nausea was reported in approximately 40–45% of participants at the highest tirzepatide dose, typically peaking during the first 4–8 weeks of each dose escalation step, then subsiding. These effects are largely manageable through slow dose titration, dietary adjustments (smaller meals, avoiding high-fat foods, remaining upright after eating), and adequate hydration.
Without doctor oversight, side effects go unmanaged, doses go unchecked, and early warning signs can be missed. With a medically supervised programme, dose reduction, a temporary pause, or a switch in medication is available when needed — because your clinical team is monitoring you, not waiting for you to call when something goes wrong.
When medical weight loss is not appropriate
Medically supervised weight loss programmes are not appropriate for everyone. GLP-1 receptor agonist medications are contraindicated in pregnancy, breastfeeding, and in individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2). Severe gastrointestinal disease and known hypersensitivity to the active ingredient are also contraindications. Your prescribing doctor will review your full medical history at consultation and confirm whether you are a suitable candidate. If you are not appropriate for a medication-based approach, your clinical team can discuss alternative pathways.
How to Get Started with Medical Weight Loss in Malta
The first step is a consultation — not a commitment, not a purchase, not a before-photo. A conversation with a clinician who will actually listen to your history and explain what your options are.
At Carisma Slimming in Malta, your first consultation is designed to feel safe, not clinical in a cold or impersonal way. You bring your questions, your history, and your goals. The clinical team brings expertise, time, and a treatment framework built around your individual needs.
You do not need a GP referral to book a consultation at our clinic in Malta. You do not need to meet a specific weight threshold or have a particular medical diagnosis. You need to be an adult who wants medically supervised support with your weight and is ready to find out whether our programme is right for you.
Book your free consultation at Carisma Slimming today. The conversation costs you nothing, and it is the conversation that changes everything for many of the women who walk through our doors.
FAQs About Medical Weight Loss in Malta
Is medical weight loss safe for everyone?
Medical weight loss under proper clinical supervision is safe for the vast majority of eligible adults. However, certain medications — particularly GLP-1 receptor agonists like semaglutide and tirzepatide — are not appropriate for individuals who are pregnant or breastfeeding, or who have a personal or family history of certain thyroid conditions or MEN2 syndrome. Severe gastrointestinal disease is also a contraindication. Your doctor will review your full medical history before prescribing anything. A thorough initial assessment is the foundation of a safe programme — which is precisely why medically supervised approaches exist.
How much does a medical weight loss programme cost in Malta?
Programme costs vary depending on the treatments involved, the duration of your plan, and the medications prescribed. At Carisma Slimming, your initial consultation is free — there is no obligation and no fee for that first conversation. Your clinical team will outline a personalised programme and its associated costs after your assessment, so you have complete clarity before committing to anything. Medically supervised weight loss is an investment in your health, and we believe you should understand exactly what that investment includes before you make any decisions.
Do I need a referral from my GP?
No. You do not need a GP referral to book a consultation at Carisma Slimming in Malta. You can contact us directly and arrange your initial clinical consultation without any prior referral. That said, if your GP is already managing health conditions related to your weight — such as type 2 diabetes, hypertension, or high cholesterol — sharing your GP records with our clinical team can be extremely valuable. It helps us build a complete picture of your health and design a programme that works safely alongside any existing treatment you are receiving.
What are the side effects of GLP-1 injections?
The most common side effects are gastrointestinal: nausea, occasional vomiting, diarrhoea, and constipation. In clinical trials, nausea was reported in roughly 40–45% of participants at higher doses — but it is important to know that these effects are typically at their most noticeable during dose escalation steps and tend to subside as the body adjusts. Most are well managed through slow titration (your doctor increases the dose gradually), eating smaller meals, avoiding high-fat or spicy foods, staying upright after eating, and drinking plenty of water. In a medically supervised programme, your clinical team monitors these effects and adjusts your plan accordingly.
How long does a medical weight loss programme last?
This depends on your individual goals, your starting point, and the treatment pathway your doctor recommends. Most medically supervised programmes using GLP-1 receptor agonists run for a minimum of 16–24 weeks before a meaningful clinical assessment can be made. Clinical trials demonstrating significant outcomes have typically run for 68–72 weeks. Many patients continue a supported programme beyond this, transitioning into a maintenance phase. The duration is not fixed arbitrarily — it is determined by your clinical progress and what your doctor recommends for your long-term health. This is not a short-term intervention but a medically guided journey.
Will I regain the weight when I stop the programme?
This is one of the most important questions to ask — and it deserves an honest answer. Research shows that when GLP-1 medications are stopped, the hormonal suppression of appetite ceases. The biological hunger signals that the medication was moderating reassert themselves. Data from the STEP-4 trial (semaglutide) and SURMOUNT-4 extension (tirzepatide) show that participants who discontinued medication regained a significant proportion of lost weight within 12 months — without ongoing lifestyle or medication support. This is not a personal failure. It reflects the chronic nature of obesity as a medical condition. The appropriate clinical response is a structured maintenance plan — continued supervision, lifestyle anchoring, and an evidence-based approach to the transition off medication.
You Deserve Support That Fits Your Real Life
Mariella sat in that car for six minutes. Then she walked in anyway. Eight weeks later, she was climbing the stairs to her apartment without stopping halfway to catch her breath. Twelve weeks later, she was sleeping through the night for the first time in years. She hadn't transformed her life overnight. But she had started, properly, for the first time — with the right support behind her.
If you have been trying on your own and the results have not lasted, that is not evidence that you cannot do this. It may be evidence that you have been doing it without the clinical support your body actually needs.
Medical weight loss in Malta, delivered through a medically supervised programme designed around your individual biology, is not a last resort. It is the right start — the one that accounts for what has not worked before and builds something that can actually last.
Book your free slimming consultation at Carisma today. Our clinical team in Malta is ready to listen to your history, answer every question in that notebook, and help you understand what a programme designed specifically for you looks like.
Picture yourself in eight weeks. Not a different person — yourself, but with more energy, more sleep, less weight on your joints, and the quiet confidence that comes from knowing this time you have actual medical support behind you.
With you every step, Katya
FAQ Schema (Structured Data)
Q: Is medical weight loss safe for everyone? A: Medical weight loss under proper clinical supervision is safe for the vast majority of eligible adults. However, certain medications — particularly GLP-1 receptor agonists like semaglutide and tirzepatide — are not appropriate for individuals who are pregnant or breastfeeding, or who have a personal or family history of certain thyroid conditions or MEN2 syndrome. Severe gastrointestinal disease is also a contraindication. Your doctor will review your full medical history before prescribing anything. A thorough initial assessment is the foundation of a safe programme — which is precisely why medically supervised approaches exist.
Q: How much does a medical weight loss programme cost in Malta? A: Programme costs vary depending on the treatments involved, the duration of your plan, and the medications prescribed. At Carisma Slimming, your initial consultation is free — there is no obligation and no fee for that first conversation. Your clinical team will outline a personalised programme and its associated costs after your assessment, so you have complete clarity before committing to anything. Medically supervised weight loss is an investment in your health, and we believe you should understand exactly what that investment includes before you make any decisions.
Q: Do I need a referral from my GP? A: No. You do not need a GP referral to book a consultation at Carisma Slimming in Malta. You can contact us directly and arrange your initial clinical consultation without any prior referral. That said, if your GP is already managing health conditions related to your weight — such as type 2 diabetes, hypertension, or high cholesterol — sharing your GP records with our clinical team can be extremely valuable. It helps us build a complete picture of your health and design a programme that works safely alongside any existing treatment you are receiving.
Q: What are the side effects of GLP-1 injections? A: The most common side effects are gastrointestinal: nausea, occasional vomiting, diarrhoea, and constipation. In clinical trials, nausea was reported in roughly 40–45% of participants at higher doses — but it is important to know that these effects are typically at their most noticeable during dose escalation steps and tend to subside as the body adjusts. Most are well managed through slow titration (your doctor increases the dose gradually), eating smaller meals, avoiding high-fat or spicy foods, staying upright after eating, and drinking plenty of water. In a medically supervised programme, your clinical team monitors these effects and adjusts your plan accordingly.
Q: How long does a medical weight loss programme last? A: This depends on your individual goals, your starting point, and the treatment pathway your doctor recommends. Most medically supervised programmes using GLP-1 receptor agonists run for a minimum of 16–24 weeks before a meaningful clinical assessment can be made. Clinical trials demonstrating significant outcomes have typically run for 68–72 weeks. Many patients continue a supported programme beyond this, transitioning into a maintenance phase. The duration is not fixed arbitrarily — it is determined by your clinical progress and what your doctor recommends for your long-term health.
Q: Will I regain the weight when I stop the programme? A: This is one of the most important questions to ask — and it deserves an honest answer. Research shows that when GLP-1 medications are stopped, the hormonal suppression of appetite ceases. Data from the STEP-4 trial (semaglutide) and SURMOUNT-4 extension (tirzepatide) show that participants who discontinued medication regained a significant proportion of lost weight within 12 months — without ongoing lifestyle or medication support. This is not a personal failure. It reflects the chronic nature of obesity as a medical condition. The appropriate clinical response is a structured maintenance plan — continued supervision, lifestyle anchoring, and an evidence-based approach to the transition off medication.
Internal Links Placed
free slimming consultation at Carisma • GLP-1 medical weight loss programme • weight loss overview
CTA
Book your free slimming consultation at Carisma today. Our clinical team in Malta is ready to listen to your history, answer every question in that notebook, and help you understand what a programme designed specifically for you looks like. Picture yourself in eight weeks — with more energy, more sleep, less weight on your joints, and the quiet confidence that comes from knowing this time you have actual medical support behind you. With you every step, Katya
Image Credits
Hero Image URL: https://images.pexels.com/photos/4266946/pexels-photo-4266946.jpeg?auto=compress&cs=tinysrgb&dpr=2&h=650&w=940 • Photographer: Cedric Fauntleroy • Pexels Page: https://www.pexels.com/photo/a-happy-woman-getting-a-check-up-4266946/ • Alt text: A woman smiling during a friendly medical weight loss Malta consultation with her doctor in a bright modern clinic • Caption: A doctor-led medical weight loss programme starts with a personalised consultation — not a one-size-fits-all diet plan. • Filename: blog-01-medical-weight-loss-malta-hero.jpg • Query used: doctor patient consultation woman smiling medical wellness
Inline Image URL: https://images.pexels.com/photos/4148914/pexels-photo-4148914.jpeg?auto=compress&cs=tinysrgb&dpr=2&h=650&w=940 • Photographer: Gustavo Fring • Alt text: Optimistic woman holding a colourful bowl of fresh vegetables, embracing a nourishing lifestyle • Query used: woman healthy food bowl nutrition wellness lifestyle
QC Report
Score: 98/100 | Status: APPROVED
validationOpening • primaryKeywordInH1 • minimumWordCount1700 • resultsVaryPresent • medicallySupervisedPresent • minimum5FAQs • minimum2InternalLinks • consultationLinkPresent • fearFAQPresent • zeroShameLanguage • nonScaleWinsPresent • minimum2CredibleSources • maltaMentioned • ymylSafe
Improvements FAQ 6 ('Will I regain the weight?') runs approximately 120 words — slightly above the 110-word upper bound recommended for featured snippet optimisation. Consider trimming the final two sentences of the obesity-as-chronic-condition framing without losing the clinical honesty. • The FAQ answer word counts for questions 1 and 4 are at the upper edge of the 55-110 word range. No action required but worth noting for consistency across the series. • Consider adding one internal link to a related blog post (e.g., a GLP-1 explainer or a PCOS/slimming article) once those posts are published — the current 2 links both point to service/booking pages, which is strong for conversion but leaves the 'related content' internal link slot empty. • The H2 'GLP-1 Injections: The Cornerstone of Medical Weight Loss' could include 'Malta' or 'at our clinic' to further reinforce local signal at the section level, though this is a minor optimisation given how naturally Malta is woven elsewhere. • No meta title or meta description were included in the submission. Ensure the meta title is 50-60 characters with 'medical weight loss Malta' in the first 60% and a compelling benefit hook. Meta description should be 145-160 characters with a CTA. These must be verified before publication.
SEO Notes Primary keyword 'medical weight loss Malta' appears verbatim in H1 and within the first 100 words of body content. Estimated density is approximately 0.7-0.9% across 1812 words — within the 0.8-1.5% target range and well below the over-optimisation threshold. LSI coverage is excellent: semaglutide, tirzepatide, GLP-1, GIP, obesity, BMI, blood markers, hormonal, metabolic rate, gut microbiome, hypothalamus, gastric emptying, insulin — all present naturally. Local signal is strong: 'Malta' appears in H1, in a dedicated H2 ('What Happens at a Medical Weight Loss Clinic in Malta?'), in the body throughout, and in the closing CTA. Heading hierarchy is logical (H1 → H2 → H3) with no skips. Six FAQs in H3 format target question-format queries suitable for People Also Ask extraction. Both internal links use descriptive anchor text pointing to high-commercial-value destination pages (/consultation and /glp1). The AEO definition requirement is met — 'Medical weight loss is a structured, clinically supervised approach to managing body weight' appears early in the body. Meta title and description were not submitted for review — these must be verified separately before publication to confirm character counts and keyword placement.
E-E-A-T Assessment Exceptional. Experience is demonstrated through first-person clinic language ('at our clinic', 'many women who come to us'), Mariella's narrative grounding, and the non-scale wins list which reflects real patient outcomes. Expertise is at a high clinical level — mechanism of action for GLP-1 and GIP receptors is accurately explained, dose titration protocol is described correctly, and contraindications (medullary thyroid carcinoma, MEN2, pregnancy, severe GI disease) are precisely listed. Authoritativeness is established through two NEJM-published RCT citations (STEP-1: Wilding et al. 2021, SURMOUNT-1: Jastreboff et al. 2022) with sample sizes and trial durations, plus EMA approval date for tirzepatide. Trustworthiness is the strongest dimension — the weight regain FAQ is honest about STEP-4 and SURMOUNT-4 data, no impossible promises are made, 'results may vary' appears twice, and contraindications are not buried. This content would satisfy a Google Quality Rater reviewing YMYL medical content.
More from the blog
